Bioventix PLC (LON:BVXP - Get Free Report)'s share price reached a new 52-week low on Monday . The company traded as low as GBX 3,200 ($41.50) and last traded at GBX 3,278 ($42.51), with a volume of 46083 shares changing hands. The stock had previously closed at GBX 3,600 ($46.69).
Bioventix Price Performance
The company's fifty day moving average price is GBX 3,964.07 and its 200 day moving average price is GBX 4,209.03. The company has a market cap of £171.11 million, a PE ratio of 2,011.04 and a beta of 0.35.
Bioventix Increases Dividend
The company also recently announced a dividend, which will be paid on Thursday, November 21st. Stockholders of record on Thursday, November 7th will be issued a GBX 87 ($1.13) dividend. The ex-dividend date is Thursday, November 7th. This represents a dividend yield of 2.4%. This is an increase from Bioventix's previous dividend of $68.00. Bioventix's dividend payout ratio is currently 9,693.25%.
Bioventix Company Profile
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
